EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Artificial Intelligence‐Empowered Single‐Cell Phenotyping for Rapid, Automated Pathogen Diagnostics

Sabita Khadka, Bushra Raahat, Spyros Tragoudas, Hui Li iD

Advanced Science · 2026-11 · 13 (62)

DOI: 10.1002/advs.77334 ↗

At a glance

Journal article in Advanced Science, published online on 2026-08-21. Written by Sabita Khadka and 3 co-authors. Institution: School of Electrical, Computer, and Biomedical Engineering, Southern Illinois University, Carbondale, Illinois, USA. Major MEDLINE topics: Single-Cell Analysis, Escherichia coli, Artificial Intelligence. 56 references. The full text is freely available (open access, CC BY 4.0). Funded by: Southern Illinois University, SIU System Collaborative Grant Award.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Accurate bacterial identification and antimicrobial susceptibility testing (AST) are essential for timely clinical decision‐making. Conventional diagnostic methods typically require 24–48 h, leading to inappropriate empirical therapy, accelerating antimicrobial resistance, and worsening patient outcomes. Here, we present an integrated diagnostic platform that combines microfluidic single‐cell bacterial detection with artificial intelligence (AI)‐driven analysis for rapid phenotypic AST. The microfluidic device enables stable time‐lapse detection of individual bacterial cells under designated, controlled antibiotic exposure, with a U‐Net–based AI model that automatically segments and quantifies the drug response of individual bacterial cells using phase‐contrast microscopy images. The trained model identified 96% of individual Escherichia coli ( E. coli ) cells and showed no false‐positive predictions on bacteria‐free images. Applied to AST, the integrated system quantified dose‐dependent growth inhibition of E. coli exposed to ciprofloxacin and trimethoprim/sulfamethoxazole, yielding resistance profiles, along with minimum inhibitory concentrations (MICs), within 2 h. These results are consistent with standard broth microdilution, demonstrating the potential of integrating microfluidics and AI for rapid, automated, and single‐cell–resolved pathogen diagnosis. Beyond rapid AST, the integrated microfluidic‐AI platform was further evaluated for automated identification of targeted infections, including E. coli and Staphylococcus aureus ( S. aureus ) in the presence of blood matrices.

Subjects

MeSH terms (MEDLINE)

Single-Cell AnalysisEscherichia coliArtificial IntelligenceMicrobial Sensitivity TestsHumansAnti-Bacterial AgentsPhenotypeMicrofluidics

Author keywords

deep learning analysisinfection diagnosisrapid antimicrobial susceptibility testsingle‐cell detection

Substances

Anti-Bacterial Agents

Authors and institutions

  • School of Electrical, Computer, and Biomedical Engineering, Southern Illinois University, Carbondale, Illinois, USA.

ORCID profiles: Hui Li

Funding

  • Southern Illinois University
  • SIU System Collaborative Grant Award

Cite

APA

Khadka, S., Raahat, B., Tragoudas, S., & Li, H. (2026). Artificial Intelligence‐Empowered Single‐Cell Phenotyping for Rapid, Automated Pathogen Diagnostics. Advanced Science, 13(62). https://doi.org/10.1002/advs.77334

Vancouver

Khadka S, Raahat B, Tragoudas S, Li H. Artificial Intelligence‐Empowered Single‐Cell Phenotyping for Rapid, Automated Pathogen Diagnostics. Advanced Science. 2026;13(62). doi:10.1002/advs.77334

BibTeX
@article{Khadka2026,
  author = {Khadka, Sabita and Raahat, Bushra and Tragoudas, Spyros and Li, Hui},
  title = {Artificial Intelligence‐Empowered Single‐Cell Phenotyping for Rapid, Automated Pathogen Diagnostics},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {62},
  doi = {10.1002/advs.77334}
}
Start for free →